NVIDIA Corp (NVDA)

In the dynamic world of financial markets, volatility stands as a constant, yet often unsettling, companion. It describes the magnitude and frequency of price fluctuations in assets like stocks, bonds, and commodities, acting as a crucial barometer for risk and uncertainty. While often perceived negatively, associated with sharp declines, volatility

The stock market experienced a robust start to the week of November 11, 2025, with major U.S. indexes surging on Monday, November 10th. This powerful rally was largely driven by a confluence of positive developments: growing optimism surrounding a potential resolution to the prolonged U.S. government shutdown and

The technology sector is currently navigating a period of significant turbulence, marked by a pronounced stock sell-off and a subsequent, albeit strategic, market consolidation. As of November 2025, financial markets are grappling with a palpable shift in investor sentiment, moving from unbridled optimism to cautious prudence. This re-evaluation is primarily

As of November 2025, the Canadian financial landscape is a crucible of innovation and caution, particularly within the realm of TSX penny stocks. The burgeoning influence of Artificial Intelligence (AI) has cast a long shadow, simultaneously igniting speculative fervor and raising significant concerns over potentially inflated valuations. This dynamic is

November 11, 2025 - The U.S. stock market is currently navigating a period of stark divergence, with the technology-heavy Nasdaq Composite experiencing significant selling pressure while the more diversified Dow Jones Industrial Average and S&P 500 exhibit surprising resilience, and even gains. This split performance signals a profound

In a financial landscape increasingly defined by rapid rebounds and seemingly endless upward trajectories, a powerful bullish sentiment has taken root, transforming market pullbacks from moments of trepidation into eagerly awaited buying opportunities. As of late 2025, the pervasive "buy the dip" mentality is not merely a strategy but a

November 11, 2025 - The financial markets witnessed a Tale of Two Tech Titans today, with AppLovin (NASDAQ: APP) experiencing a significant surge in its market capitalization, while AI cloud specialist CoreWeave (NASDAQ: CRWV) faced a notable downturn. These contrasting movements highlight the delicate balance between robust financial performance and

As November 2025 unfolds, a palpable sense of apprehension grips global financial markets, fueled by mounting investor concerns over a potential Artificial Intelligence (AI)-driven market bubble. The once-unbridled enthusiasm surrounding AI innovation is now tempered by a critical reassessment of sustainability, leading to increased volatility and a noticeable shift

Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025. The chip giant, a foundational pillar of the artificial intelligence (AI) revolution, has seen its immense market capitalization—

TOKYO, Japan – November 11, 2025 – In a seismic strategic maneuver that sent ripples across the global technology landscape, SoftBank Group (TYO: 9984) announced today the complete divestment of its remaining stake in chip giant Nvidia (NASDAQ: NVDA). The Japanese conglomerate offloaded 32.1 million shares in October 2025, netting a staggering $5.83 billion. This [...]

As of November 11, 2025, the financial markets are witnessing a significant and ongoing rotation of investment capital, moving away from the high-flying technology sector, including Artificial Intelligence (AI) powerhouses, and into more established, traditional industries. This pivotal shift is primarily driven by escalating valuation concerns within the tech space

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

AI boom reshaping corp. balance sheets, Nebius NV plans to raise capital for expansion through debt, following path of Meta & Oracle.

Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!

CoreWeave's depreciation schedule is similar to the big hyperscalers.

Shares of visual content marketplace Getty Images (NYSE:GETY) fell in the afternoon session after the company reported mixed third-quarter 2025 results. The visual content marketplace reported revenue of $240 million, which was flat year-over-year but in line with Wall Street's estimates. The main highlight for investors was the company's profitability. Getty reported adjusted earnings per share of $0.08, which was 84.5% higher than the consensus analyst estimate of $0.04. The company also beat expectations for adjusted EBITDA, a key measure of profitability, coming in at $78.71 million. Adding to the positive sentiment, Getty Images' full-year EBITDA guidance of $292 million at the midpoint was also above analysts' projections.

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 0.6% in the afternoon session after Canaccord Genuity Group raised its price target on the stock. The analyst firm lifted its target to $19.00 from $16.00 and kept a "buy" rating on the shares. 

Shares of electric vehicle charging company EVgo (NASDAQ:EVGO) fell 4.2% in the afternoon session after the stock's negative momentum continued as the company reported mixed third-quarter financial results that showed strong revenue growth but also a failure to meet sales expectations and a slightly wider-than-projected loss. 

Shares of pharmaceutical company Organon (NYSE:OGN) fell 2.9% in the afternoon session after the company lowered its full-year sales guidance and analysts subsequently cut their price targets on the stock. This outlook overshadowed a third-quarter report where both earnings and revenue topped estimates. Following the earnings release, Organon provided a sales forecast that fell below analysts' expectations, prompting a reassessment of the company's value. JPMorgan reduced its price target to $12 from $14, citing headwinds for the company's Nexplanon and respiratory products. In a similar move, Morgan Stanley lowered its price target to $9 from $10, while maintaining its "Equal-Weight" rating on the shares.

Shares of vacation ownership company Marriott Vacations (NYSE:VAC) fell 7.3% in the afternoon session after an analyst at Mizuho downgraded the company's stock. The rating was moved from "Outperform" to "Neutral," and the price target was significantly cut by over 31% from $85.00 to $58.00. This analyst action appeared to reverse the positive sentiment from the previous day, when the stock jumped after the company announced the immediate departure of its CEO, John Geller. Matthew E. Avril was appointed as the interim chief executive. The downgrade from Mizuho followed other recent price target reductions from firms including Citizens and Barclays, signaling growing concerns among analysts about the company's outlook.

Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) fell 3.1% in the afternoon session after Japanese tech investment giant SoftBank announced it had sold its entire stake in the artificial intelligence company. In an earnings statement, SoftBank confirmed it had offloaded its shares for $5.83 billion. While the company stated the sale was part of a push for "asset monetization," the move was seen by some as a sign that SoftBank believed the best of Nvidia's stock gains were in the past. Because Nvidia is one of the largest companies on Wall Street, the sale was a heavy weight on the market. The news also added to broader concerns about high valuations in the technology sector, particularly around artificial intelligence stocks that had seen exceptional performance.

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.8% in the afternoon session after an analyst at Stephens & Co. raised the price target on the stock while maintaining a positive rating. Analyst Mason Carrico boosted the price target for Pacific Biosciences to $2.00 from $1.80, which marked an increase of over 11%. The firm also kept its 'Overweight' rating on the shares. This action signaled continued confidence from the analyst that the stock could perform well relative to others in its sector. The update provided a positive signal for investors, suggesting a more optimistic outlook on the company's valuation.

Shares of electricity storage and software provider Fluence (NASDAQ:FLNC) fell 9.7% in the afternoon session after BNP Paribas Exane downgraded the stock to 'Underperform', which appeared to overshadow recent positive news and reflect broader investor caution. The drop came even as the company partnered with LEAG Clean Power to build Europe's largest battery energy storage system. However, the downgrade reflected investor concern, which was also highlighted by high short interest in the company's shares. This cautious outlook was echoed by a broader analyst consensus, with many holding a 'Hold' rating on the stock due to persistent profitability challenges. Ultimately, the negative analyst action seemed to outweigh the positive project announcement for investors.

Shares of video communications platform Zoom (NASDAQ:ZM) rose in the afternoon session after an analyst at Rosenblatt increased the company's price target to $115 from $110 while keeping a Buy rating on the shares. The firm cited “highly bullish” channel checks and raised its revenue estimates for fiscal years 2026 and 2027 ahead of Zoom's next earnings report. The positive outlook was also tied to what the analyst called the company's “180-degree” pivot to a partner-first model. This shift in its sales approach was described as “supercharging” its efforts to bring products to market, signaling strong confidence in the company's future performance.